Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
Clinical trial NCT01349660 · COMPLETED
Trial details
- NCT number
- NCT01349660
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2016-12-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.